Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Marty

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Bulletin Du Cancer|June 30, 2015
[Meeting of the French Society of Cancer]Michel Marty
Bulletin Du Cancer|March 28, 2015
[Le Bulletin du Cancer. Editorial]Michel Marty,
European Journal of Cancer (Oxford, England : 1990)|November 5, 2005
The evolution of EMEAMichel Marty
Bulletin Du Cancer|January 15, 2017
[La Société Française du Cancer is moving forward]Marie Dutreix, Michel Marty
European Journal of Cancer (Oxford, England : 1990)|April 9, 2008
The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumabMichel Marty, Xavier Pivot
Bulletin Du Cancer|November 14, 2008
[Individualized anticancer therapies: which regulatory guidelines?]Naima Bedairia, Michel Marty
Bulletin Du Cancer|February 14, 2018
[La Société française du cancer strengthens its information and education activity]Marie Dutreix, Michel Marty
Bulletin Du Cancer|August 7, 2016
[Not Available]Marie Dutreix, Michel Marty
Bulletin Du Cancer|February 7, 2004
[Anti-epidermal growth factor receptor treatment: a new paradigm for conducting therapeutic trials]Michel Marty, Naima Bedairia, Jean-Pierre Armand
Anti-Cancer Drugs|April 7, 2011
Combining molecular targeted therapies: clinical experienceXavier Pivot, Nadia Bedairia, Antoine Thiery-Vuillemin, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Bulletin Du Cancer|June 30, 2015
[Meeting of the French Society of Cancer]Michel Marty
Bulletin Du Cancer|March 28, 2015
[Le Bulletin du Cancer. Editorial]Michel Marty,
European Journal of Cancer (Oxford, England : 1990)|November 5, 2005
The evolution of EMEAMichel Marty
Bulletin Du Cancer|January 15, 2017
[La Société Française du Cancer is moving forward]Marie Dutreix, Michel Marty
European Journal of Cancer (Oxford, England : 1990)|April 9, 2008
The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumabMichel Marty, Xavier Pivot
Bulletin Du Cancer|November 14, 2008
[Individualized anticancer therapies: which regulatory guidelines?]Naima Bedairia, Michel Marty
Bulletin Du Cancer|February 14, 2018
[La Société française du cancer strengthens its information and education activity]Marie Dutreix, Michel Marty
Bulletin Du Cancer|August 7, 2016
[Not Available]Marie Dutreix, Michel Marty
Bulletin Du Cancer|February 7, 2004
[Anti-epidermal growth factor receptor treatment: a new paradigm for conducting therapeutic trials]Michel Marty, Naima Bedairia, Jean-Pierre Armand
Anti-Cancer Drugs|April 7, 2011
Combining molecular targeted therapies: clinical experienceXavier Pivot, Nadia Bedairia, Antoine Thiery-Vuillemin, et al.
Pageof 7